Minimal residual disease in acute leukemia: lessons learned from animal models.
Hagenbeck
A
A
Radiobiological Institute TNO, Rijswijk, The Netherlands.
Martens
A C
AC
D000818:Animals; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology*; D002452:Cell Count; D002465:Cell Movement; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D014411:Neoplastic Stem Cells / Q000473:pathology; D009928:Organ Specificity; D051381:Rats; D011914:Rats, Inbred BN
D003520:Cyclophosphamide